Jan Vilcek
46Patents
18h-index
20Co-inventors
81Inventor score
Filing activity: Apr 17, 1981 → Dec 7, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5656272A | Methods of treating TNF-.alpha.-mediated Crohn's disease using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 273 | Expired |
| US7070775B2 | Recombinant A2-specific TNFα specific antibodies | Chemistry; Metallurgy | 174 | Expired |
| US5698195A | Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 173 | Expired |
| US5919452A | Methods of treating TNF.alpha.-mediated disease using chimeric anti-TNF antibodies | Chemistry; Metallurgy | 141 | Expired |
| US7276239B2 | Recombinant A2-specific TNFα-specific antibodies | Chemistry; Metallurgy | 131 | Expired |
| US6277969A | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 117 | Expired |
| US7192584B2 | Methods of treating psoriasis with anti-TNF antibodies | Chemistry; Metallurgy | 101 | Expired |
| US6284471A | Anti-TNFa antibodies and assays employing anti-TNFa antibodies | Chemistry; Metallurgy | 99 | Expired |
| US7179893B2 | Recombinant anti-TNF-α antibodies | Chemistry; Metallurgy | 67 | Expired |
| US6835823B2 | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 61 | Expired |
| US6991791B2 | Anti-TNF antibodies and peptides of human tumor necrosis factor | Chemistry; Metallurgy | 56 | Expired |
| US6790444B2 | Anti-TNF antibodies and peptides of human necrosis factor | Chemistry; Metallurgy | 51 | Expired |
| US7138118B2 | Methods of treating rheumatoid arthritis with anti-TNF antibodies | Chemistry; Metallurgy | 29 | Expired |
| US7101674B2 | Anti-idiotypic anti-TNF antibodies and related immunoassay methods | Chemistry; Metallurgy | 23 | Expired |
| US5426181A | DNA encoding cytokine-induced protein, TSG-14 | Chemistry; Metallurgy | 22 | Expired |
| US6313091A | Pharmaceutical compositions containing TSG-6 for treating inflammatory diseases and cancer-related pathologies and method | Human Necessities | 22 | Expired |
| US7226593B2 | Methods of treating cachexia with chimeric anti-TNF antibodies | Chemistry; Metallurgy | 18 | Expired |
| US7128907B2 | Methods of treating crohn's disease with anti-TNF antibodies | Chemistry; Metallurgy | 18 | Expired |
| US7227003B2 | Anti-TNF antibody fragments | Chemistry; Metallurgy | 18 | Expired |
| US4460685A | Method of enhancing the production of human .gamma. Interferon | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7128908B2 | Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof | Chemistry; Metallurgy | 15 | Expired |
| US7135178B2 | Methods of treating disseminated intravascular coagulation using anti-TNF antibodies | Chemistry; Metallurgy | 15 | Expired |
| US7135179B2 | Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof | Chemistry; Metallurgy | 15 | Expired |
| US7179466B2 | Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies | Chemistry; Metallurgy | 15 | Expired |
| US7169388B2 | Methods of inhibiting TNFα in patients with cancer | Chemistry; Metallurgy | 15 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.